 |
|
Hippocampal Volume Reduction in Schizophrenia as Assessed by Magnetic Resonance Imaging
A Meta-analytic Study
Michael D. Nelson, MA;
Andrew J. Saykin, PsyD;
Laura A. Flashman, PhD;
Henry J. Riordan, PhD
Arch Gen Psychiatry. 1998;55:433-440.
ABSTRACT
| |
Background Although many quantitative magnetic resonance imaging studies have found significant volume reductions in the hippocampi of patients with schizophrenia compared with those of normal control subjects, others have not. Therefore, the issue of hippocampal volume differences associated with schizophrenia remains in question.
Methods Two meta-analyses were conducted to reduce the potential effects of sampling error and methodological differences in data acquisition and analysis. Eighteen studies with a total patient number of 522 and a total control number of 426 met the initial selection criteria.
Results Meta-analysis 1 yielded mean effect sizes of 0.37 (P<.001) for the left hippocampus and 0.39 (P<.001) for the right, corresponding to a bilateral reduction of 4%. Meta-analysis 2 indicated that the inclusion of the amygdala in the region of interest significantly increased effect sizes across studies (effect size for the left hippocampus and amygdala, 0.67; for the right, 0.72), whereas variables such as illness duration, total slice width, magnet strength, the use of the intracranial volume as a covariate, measurement reliability, and study quality did not. No laterality differences were observed in these data.
Conclusions Schizophrenia is associated with a bilateral volumetric reduction of the hippocampus and probably of the amygdala as well. These findings reinforce the importance of the medial temporal region in schizophrenia and are consistent with frequently reported memory deficits in these patients. Future quantitative magnetic resonance imaging studies evaluating the hippocampal volume should measure the hippocampus and amygdala separately and compare the volumetric reduction in these structures to that observed in other gray matter areas.
INTRODUCTION
THE HIPPOCAMPUS has long been considered an essential component of the medial temporal lobe memory system.1-2 The literature on both humans and animals has established that hippocampal lesions result in memory deficits.1-2 Patients with schizophrenia also have been shown to suffer from memory dysfunction, and several studies suggest that this selective impairment exceeds the global neuropsychological deficits reported.3-5 Specific deficits have been found in verbal3, 5-9 and visual memory,5 including semantic memory10 and encoding,8 digit span,6-7 and design reproduction.6-7,11 Although there is some evidence to suggest that patients with schizophrenia are less significantly impaired on recognition tasks,3, 6, 11 this finding is somewhat equivocal.8
Recent studies have attempted to elucidate the anatomical correlates of memory impairment in schizophrenia as part of the general search for neuropathological correlates of the illness. Although some postmortem research has suggested that schizophrenia is associated with abnormal hippocampal pyramidal cell density12 and orientation,13-14 other studies15-16 have failed to support these findings. In addition, schizophrenia has been correlated with smaller neuron size in the CA1 region, subiculum, and layer II of the entorhinal cortex.17 Abnormalities also have been reported in the mossy fiber pathway,18 which arises from the axons of hippocampal granule cells and travels to the pyramidal cells of the CA3 region.19 Other postmortem evidence has suggested that schizophrenia is associated with reductions in overall volume of the hippocampus12, 20-21 and parahippocampal gyrus.22
Although postmortem techniques are useful in determining the neurohistological correlates of disease, their findings can be influenced by error variance associated with several variables, including the cause of death. Magnetic resonance imaging (MRI) allows for the in vivo volumetric measurement of various cerebral structures, and these techniques have been applied to the study of schizophrenia. Schizophrenia has been associated with an increased volume of the following brain components: total cerebrospinal fluid,23-24 overall ventricular cerebrospinal fluid,24-25 lateral ventricles,26-30 the third ventricle,26-27,29, 31 and the caudate.32 Decreases in volume have been found in the following structures: whole brain,24 global gray matter,33 thalamus,25, 34 prefrontal cortex and white matter,24, 32 temporal lobe gray matter,26, 29 superior temporal gyrus,35 amygdala,31-32 parahippocampal gyrus,35-36 and corpus callosum.37 Magnetic resonance imaging volumetry has also been applied to the question of hippocampal volume differences in patients with schizophrenia, with inconclusive results. Many studies have reported substantial reductions of hippocampal volume in patients with schizophrenia when compared with normal control subjects,28-29,31-32,35, 38-46 but others have not.26, 47-55 In this context, the term "reduced" refers only to a smaller relative volume in patients compared with normal control subjects. Even less clear is the issue of laterality differences in hippocampal volume.56 Considering that studies with negative findings are less likely to be published, definitive conclusions regarding hippocampal volume and laterality have remained elusive.
There are a number of reasons why results may have been equivocal. For example, the reported differences in hippocampal volume in patients with schizophrenia may be due in large part to sampling error and/or methodological variations such as magnet field strength, slice thickness, and the adjustment of hippocampal volume for either hemispheric or total intracranial volume. One of the best methods for controlling the effects of such mediating variables is the use of meta-analytic techniques.57 Meta-analysis provides a quantitative method for integrating research findings within a given body of literature so that a more definitive overall conclusion can be reached. Meta-analytic reviews have recently been conducted on MRI studies of ventricular enlargement,30 corpus callosum size in patients with schizophrenia,37 and ventricular size in patients with bipolar disorder.58 Because these studies helped to clarify many unresolved issues, a meta-analytic review of the literature evaluating hippocampal volumes is likely to be a useful tool in addressing the question of brain structural differences in schizophrenia.
This meta-analytic study was conducted to test 2 major hypotheses. First, patients with schizophrenia were predicted to have significantly smaller hippocampal volumes compared with normal control subjects. Second, we hypothesized that a moderator variable analysis would reveal important variables that could account for the divergence of results in the literature and thus inform future studies.
METHODS
STUDY SELECTION
Published reports that evaluated hippocampal volume differences between patients with schizophrenia and normal control subjects using MRI techniques were obtained through the use of computerized databases, including MEDLINE and PsychINFO, and by searching the bibliographies of relevant studies. This search identified 33 studies published between 1988 and 1997. To be included, published studies had to meet several initial criteria: means and SDs for hippocampal volumes had to be reported, a normal comparison group must have been evaluated, the region of interest (ROI) must have included the hippocampus alone or the hippocampal-amygdala complex, the mean patient age must have been between 25 and 40 years, and the study could not have used duplicate subjects from another included study. As many early studies were unable to distinguish between the hippocampus and the amygdala because of technical limitations, studies that measured the 2 structures together were not excluded. Four studies were excluded because of subject duplication,35, 45, 59-60 3 because means and SDs were not reported,50, 61-62 6 because the hippocampal area was measured instead of the volume,49, 53, 63-66 1 because control subjects were not included,67 1 because the parahippocampal gyrus was included in the ROI,68 and 1 because it evaluated elderly patients (mean age, 78.1 years).69 Therefore, 18 studies were ultimately included in this meta-analytic study, including data from our laboratory.70 Demographic information on patients and normal control subjects is provided in Table 1, and scan-related information and mean hippocampal volumes are reported in Table 2.
|
|
|
|
Table 1. Demographic Information for 522 Patients With Schizophrenia and 426 Control Subjects*
|
|
|
|
|
|
|
Table 2. Scan Information for 522 Patients With Schizophrenia Compared With 426 Control Subjects*
|
|
|
GENERAL META-ANALYTIC METHODS
All analyses were conducted according to the methods of Hedges and Olkin71 as implemented by DStat,72 a commercially available software program designed specifically for meta-analytic research. The DStat program computes both effect sizes and 95% confidence intervals. All analyses were conducted in several steps. First, Hedges g (an estimate of effect size) was computed for each study by subtracting the mean patient volume (mp) from the mean control volume (mc) and dividing by the pooled SD (s) according to the following formula72:
Although Hedges g does provide an estimate of effect size, it is susceptible to bias introduced by a low sample size.72-73 Therefore, DStat was used to transform Hedges g into an unbiased measure of effect size, the Cohen d. Individual values of d were then combined across studies and weighted according to their variance (v) using the following formulas71:
where wi represents the individual weight for a given study. If more than 1 mean was reported (eg, separate volumes for men and women), a global mean for each hippocampus was computed using the weighted average of the individual means, a strategy that has been used previously in meta-analyses.58
Laterality differences were evaluated by converting the effect size for each subset (left vs right) into the Fisher Zr and computing the difference between the 2 hippocampi (eg, subtracting the Zr associated with the left hippocampus from the Zr associated with the right hippocampus) according to the following formulas74:
(4)
(5)
(6)
Significance (P) for Cohen q was computed in the following way75:
where Z1=q=Z is associated with the experimental hypothesis (D'0) and Z0=Z is associated with the null hypothesis (D=0). SQRT signifies square root; D, overall effect size.
Readers interested in further details of meta-analytic techniques are referred to the work of Hunter and Schmidt,57 Hedges and Olkin,71 Rosenthal,73 and Cooper and Hedges.76
Meta-analysis 1
All 18 studies were included in the initial overall meta-analysis. During the initial analyses, however, it was determined that a significant outlier was present in the data set (Figure 1). Because the exclusion of outliers serves to increase the accuracy of the overall meta-analytic model through the reduction of extraneous variance,71-72 all further analyses were conducted excluding the outlier. An overall effect size (D) for each hippocampus was then obtained by computing the weighted mean across the remaining 17 studies.
|
|
|
|
Figure 1. Funnel plot (sample size vs effect size) for the 18 studies included in the initial meta-analysis. Note the presence of an outlier in the data set (lower left).
|
|
|
Meta-analysis 2
A second meta-analysis was conducted to evaluate possible moderator variables (factors that could affect results between studies). Each study was coded on several theoretically relevant variables (mean illness duration, total slice width, magnet strength, the adjustment of hippocampal volume for either hemispheric or intracranial volume, the inclusion of the amygdala in the ROI, and measurement reliability), and the studies were classified into subsets of each individual variable. As in previous meta-analyses,37 studies were rated on several quality factors that were also treated as possible moderator variables. The first factor evaluated the completeness of the demographic information reported and the degree of patient-control matching. This dimension included patient-control matching by sex, age, handedness, height, weight, education level, and parental socioeconomic status. The reporting of demographic information, including illness duration, age at illness onset, diagnostic criteria, and the source of comparison subjects, was also considered. Studies were assigned 1 point for each item addressed, except in the case of patient-control matching by education level.
Because matching by education level may result in the selection of either high-functioning patients or low-functioning control subjects (or both),77-78 studies were assigned no points if such matching was used and 1 point if it was not. The second factor was related to overall scan quality and included magnet strength, slice plus gap width, measurement reliability, the adjustment of hippocampal volume for hemispheric or total intracranial volume, and the inclusion of the amygdala in the ROI. Scores on each of these factors were then transformed into percentages. The third factor measured overall study quality, which was created by averaging the percentages from the first 2 factors.
Potential differences in effect size between variable subsets were analyzed using the method of Hedges and Olkin71 as implemented by the categorical modeling feature in DStat. This procedure computes mean effect sizes and 95% confidence intervals for each variable subset and allows for the testing of the influence of each individual factor on the overall results. Because possible moderator variables were evaluated in a univariate manner, a Bonferroni correction was used, resulting in a critical P value of .005.
RESULTS
Results of both meta-analyses are provided in Table 3. The mean effect sizes and confidence intervals for left and right hippocampi are reported for each variable subset. Note that model P refers to the probability that a given variable affected results across studies for the left and right hippocampi. The results from the overall meta-analysis indicate that schizophrenia is significantly associated with bilaterally reduced hippocampal volume (DL=0.37; DR=0.39; P<.001 for both). As shown in Figure 2, these results correspond to a bilateral reduction of approximately 4%. The large number of significant mean effect sizes shown in Table 3 reflects the overall consistency of bilaterally reduced hippocampal volume. Similar effects were observed at most levels of the potential moderator variables. No laterality differences were seen in these data.
|
|
|
|
Table 3. Results of Meta-analyses*
|
|
|
|
|
|
|
Figure 2. Percentage reduction in the hippocampal-amygdala complex (H+A) in patients with schizophrenia. With 1 exception, the studies measuring the amygdala alone also provided hippocampal measurements. The combined H+A studies do not overlap with the other groups. See the "Comment" section for details.
|
|
|
Only the inclusion of the amygdala in the ROI had a significant (P<.005) influence on effect sizes between studies, with those studies that measured both structures together having higher mean effect sizes (left, 0.67; right, 0.72), equaling a bilateral reduction of 8% (Figure 2). To further assess this potential relationship, studies32, 48, 52, 54, 68 that measured the amygdala separately were evaluated, 4 of which were included in the hippocampal analyses.33, 48, 52, 54 Results of this analysis indicated a similar association between schizophrenia and volumetric reduction of the amygdala. The mean effect sizes were 0.29 for the left amygdala and 0.30 (P<.05 for both) for the right, equal to an approximately 4.5% reduction in volume (Figure 2). None of the other putative moderator variables had a significant effect on the results.
COMMENT
These meta-analyses produced several main results. First, there is a significant association between schizophrenia and bilateral volumetric reduction of the hippocampus. Second, the inclusion of the amygdala in the ROI significantly increased the magnitude of this relationship. No differences in volumetric reduction were observed between the left and right hippocampi. Finally, it appears that publication bias in favor of positive findings is unlikely to be a significant confounding variable in this literature because many of the studies evaluated in this meta-analysis reported results that were either nonsignificant or opposite the hypothesized direction (Figure 1 and Table 2).
These results have theoretical and methodological implications. Our finding of significant bilateral hippocampal volume reduction is consistent with the nature of the memory and cytoarchitectural abnormalities associated with schizophrenia. Patients with schizophrenia show specific memory deficits consistent with both left3-7,9, 11 and right5-7,11 hippocampal disease. Schizophrenia also has been associated with reduced hippocampal pyramidal cell density, most notably in the left anterior CA3 and CA4 regions.12
The finding that the inclusion of the amygdala in the hippocampal ROI significantly increased the mean effect size suggests that volumetric reduction of the amygdala may also be associated with schizophrenia. Note that in Figure 2 the reduction observed in those studies that measured the hippocampus and the amygdala together ("Combined H+A") was approximately 8%. Because most of the studies in the group in which the hippocampus and the amygdala were measured together had large slice widths (Table 2), however, the greater hippocampus-amygdala reduction observed in these studies could be due to partial volume effects or other measurement factors. Therefore, we recommend measuring the hippocampus and amygdala separately and in their entirety so that the volume of each structure can be assessed independently. The ability of modern scanners to delineate the alveus allows for the accurate separation of the amygdala from the anterior hippocampus.79
Although neither the magnet strength nor the slice width had a significant effect on the quantitative volumetric measurement of the hippocampus in this sample, future MRI assessment of relatively small brain structures (ie, hippocampus) should be conducted using the best available scanning technology. For example, the total slice width has been shown to have a significant effect on the volumetric MRI measurement.80 Using a calibrated phantom, Luft et al80 demonstrated that slice widths greater than 3.0 mm lead to significantly increased error rates. Furthermore, it has been strongly recommended that MRI data be acquired or at least reformatted into a plane perpendicular to the long axis of the hippocampus, a process that helps correct for individual variations in head position.79
Although the adjustment of the volume of small cerebral structures for hemispheric or total intracranial volume has been thought to facilitate the accuracy of their measurement,79 the results of the moderator variable analysis failed to confirm this hypothesis. Therefore, it is unlikely that the observed differences in the hippocampal volume in patients with schizophrenia are due to a reduction in overall brain volume. Because people with larger heads and brains tend to have larger hippocampi,39, 79 however, this correction appears warranted because it helps control for the confounding influence of overall brain volume.
Differences in interrater reliability, scan quality, demographic or subject matching quality, and overall quality did not influence the overall effect size in these meta-analyses. This may be due to a range restriction and the lack of variability in these dimensions, which were of consistently good quality across studies. These dimensions are clearly important. Large differences in interrater reliability can contribute to interstudy variation.79 Also, the matching of patients and normal control subjects and the reporting of clinical and demographic information are necessary components of any quantitative MRI investigation involving clinical populations.
There are several limitations of this meta-analytic study. First, given the nature of the selection of studies that were included, there is no guarantee that many studies reporting either nonsignificant or countertheoretical results were not published. This problem is unlikely to have significantly influenced the overall conclusions of this study, however, because many of the analyzed studies did report negative results. Second, meta-analytic studies have been criticized for including studies of varying methods.57 The inclusion of studies using different methodological techniques in this case revealed an important moderator variable that may account for some of the discrepancies in the published literature. Third, it was not possible to adequately compare the level of hippocampal volume reduction with that of other gray matter structures (except the amygdala) in these patients. Therefore, it is unclear whether our results are indicative of specific hippocampal volume reduction or a more general reduction in gray matter in patients with schizophrenia.24, 26, 29, 31-33,35-36,56, 81 Fourth, the influence of gender and handedness on hippocampal volume reduction could not be evaluated because of the inclusion of mostly right-handed men in the available studies. Finally, the total number of studies was sufficient for univariate analyses but not for multivariate meta-analytic techniques assessing conjoint and interactive effects of moderator variables.
Future research on the cerebral morphometric correlates of schizophrenia should focus on several issues. First, longitudinal studies should be undertaken to assess the independent effects of patient age and illness duration on the volume of the hippocampus and other structures. Such an approach is important because neuroanatomical abnormalities may be present early in the disease25, 50-51,67, 82 and consequently interact with normal aging. Second, more female and left-handed subjects should be sampled to evaluate possible volumetric differences related to gender and handedness. Third, the relationship between the pattern of clinical symptoms and cognitive profile of patients with schizophrenia and the volume of implicated structures such as the parahippocampal gyrus, amygdala, prefrontal cortex, cingulate gyrus, and thalamus should be investigated. Fourth, concurrent volumetric and functional MRI studies should be undertaken to address the functional consequences and correlates of reduced hippocampal volume and differential role of the left and right hippocampus. Fifth, the volumetric reduction of the hippocampus vs that of other gray matter structures should be compared because, as noted earlier, such reductions have been associated with schizophrenia, including the first episode of the illness.50-51,67, 82 Sixth, the relative involvement of the anterior and posterior hippocampus in the disease process of schizophrenia should be compared. Because these 2 subdivisions of the hippocampus have different afferent and efferent connections,67 it is possible that they may be differentially affected in schizophrenia. Seventh, studies should report the anatomical boundaries used to separate the hippocampus and amygdala in enough detail to allow others to replicate them because differences in these boundaries have the potential to affect volumetry results.79 Finally, future studies need to elucidate the underlying mechanism of reduced hippocampal and amygdalar volume in advancing an etiologic understanding of this illness. Recent neurobiological studies in other mammalian species have indicated that environmental factors such as enrichment83 and psychosocial stress84 can alter neurogenesis in the hippocampus. The possible developmental interactions among genetic and other neurobehavioral risks and environmental advantages and stressors should be a fruitful area of investigation in schizophrenia.
AUTHOR INFORMATION
Accepted for publication October 31, 1997.
This research was supported in part by the New Hampshire Hospital, Concord; grant RO1-NS28813 from the National Institutes of Health, Bethesda, Md; a grant from the National Alliance for Research on Schizophrenia and Depression, Chicago, Ill; and grant IIRG-94-133 from the Alzheimer's Association, Chicago.
We thank Lee Friedman, PhD; Howard C. Hughes, PhD; Sterling Johnson, PhD; Virginia Reed, PhD; Cynthia Smith, PhD; and 6 anonymous reviewers for their valuable comments on earlier versions of the manuscript.
Reprints: Andrew Saykin, PsyD, Department of Psychiatry, Dartmouth Medical School, 1 Medical Center Dr, Lebanon, NH 03756 (e-mail: saykin{at}dartmouth.edu).
From the Department of Psychology, Dartmouth College, Hanover (Mr Nelson and Dr Saykin); the Brain Imaging Laboratory, Department of Psychiatry (Mr Nelson and Drs Saykin, Flashman, and Riordan), and the Department of Radiology (Dr Saykin), Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, Lebanon; and the New Hampshire Hospital, Concord (Drs Saykin and Flashman), NH.
REFERENCES
| |
1. Squire LR, Zola-Morgan S. The medial temporal lobe memory system. Science. 1991;253:1380-1386.
FREE FULL TEXT
2. Milner B. Disorders of learning and memory after temporal lobe lesions in man. Clin Neurosurg. 1972;19:421-446.
PUBMED
3. Saykin AJ, Gur RC, Gur RE, Mozley D, Mozley LH, Resnick SM, Kester DB, Stafiniak P. Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch Gen Psychiatry. 1991;48:618-624.
ISI
| PUBMED
4. McKenna PJ, Tamlyn D, Lund CE, Mortimer AM, Hammond S, Baddeley AD. Amnesic syndrome in schizophrenia. Psychol Med. 1990;20:967-972.
ISI
| PUBMED
5. Saykin AJ, Shtasel DL, Gur RE, Kester DB, Mozley LH, Stafiniak P, Gur RC. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry. 1994;51:124-131.
ISI
| PUBMED
6. Beatty WW, Jocic Z, Monson N, Staton RD. Memory and frontal lobe dysfunction in schizophrenia and schizoaffective disorder. J Nerv Ment Dis. 1993;181:448-453.
ISI
| PUBMED
7. Goldberg TE, Torrey EF, Gold JM, Ragland JD, Bigelow LB, Weinberger DR. Learning and memory in monozygotic twins discordant for schizophrenia. Psychol Med. 1993;23:71-85.
ISI
| PUBMED
8. Gold JM, Randolph C, Carpenter CJ, Goldberg TE, Weinberger DR. Forms of memory failure in schizophrenia. J Abnorm Psychol. 1992;101:487-494.
FULL TEXT
|
ISI
| PUBMED
9. Sengel RA, Lovallo WR. Effects of cueing on immediate and recent memory in schizophrenics. J Nerv Ment Dis. 1983;171:426-430.
ISI
| PUBMED
10. Tamlyn D, McKenna PJ, Mortimer AM, Lund CE, Hammond S, Baddeley AD. Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character. Psychol Med. 1992;22:101-115.
ISI
| PUBMED
11. Calev A, Korin Y, Kugelmass S, Lerer B. Performance of chronic schizophrenics on matched word and design recall tasks. Biol Psychiatry. 1987;22:699-709.
FULL TEXT
|
ISI
| PUBMED
12. Jeste DV, Lohr JB. Hippocampal pathologic findings in schizophrenia: a morphometric study. Arch Gen Psychiatry. 1989;46:1019-1024.
ISI
| PUBMED
13. Conrad AJ, Abebe T, Austin R, Forsythe S, Scheibel AB. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch Gen Psychiatry. 1991;48:413-417.
ISI
| PUBMED
14. Kovelman JA, Scheibel AB. A neurohistological correlate of schizophrenia. Biol Psychiatry. 1984;19:1601-1621.
ISI
| PUBMED
15. Altshuler LL, Conrad AJ, Kovelman JA, Scheibel AB. Hippocampal pyramidal cell orientation in schizophrenia: a controlled neurohistologic study of the Yakovlev collection. Arch Gen Psychiatry. 1987;44:1094-1098.
ISI
| PUBMED
16. Christison GW, Casanova MF, Weinberger DR, Rawlings R, Kleinman JE. A quantitative investigation of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia. Arch Gen Psychiatry. 1989;46:1027-1032.
ISI
| PUBMED
17. Arnold SE, Franz BR, Gur RC, Gur RE, Shapiro RM, Moberg PJ, Trojanowski JQ. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry. 1995;152:738-748.
FREE FULL TEXT
18. Goldsmith SK, Joyce JN. Alterations in hippocampal mossy fiber pathway in schizophrenia and Alzheimer's disease. Biol Psychiatry. 1995;37:122-126.
FULL TEXT
|
ISI
| PUBMED
19. Kandel ER. Cellular mechanisms of learning and the biological basis of individuality. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of Neural Science. 3rd ed. New York, NY: Elsevier Science; 1991:chap 65.
20. Bogerts B, Falkai P, Greve B, Schneider T, Pfeiffer U. The neuropathology of schizophrenia: past and present. J Hirnforsch. 1993;34:193-205.
PUBMED
21. Bogerts B, Meertz E, Bausch-Schonfeldt R. Basal ganglia and limbic system pathology in schizophrenia: a morphometric study of brain volume and shrinkage. Arch Gen Psychiatry. 1985;42:784-791.
ISI
| PUBMED
22. Colter N, Battal S, Crow TJ, Johnstone EC, Brown R, Burton C. White matter reduction in the parahippocampal gyrus of patients with schizophrenia [letter]. Arch Gen Psychiatry. 1987;44:1023.
23. Gur RE, Mozley D, Resnick SM, Shtasel D, Kohn M, Zimmerman R, Herman G, Atlas S, Grossman R, Erwin R, Gur RC. Magnetic resonance imaging in schizophrenia, I: volumetric analysis of brain and cerebrospinal fluid. Arch Gen Psychiatry. 1991;48:407-412.
ISI
| PUBMED
24. Andreasen NC, Flashman L, Flaum M, Arndt S, Swayze II V, O'Leary DS, Ehrhardt JC, Yuh WTC. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA. 1994;272:1763-1769.
ABSTRACT
25. Corey-Bloom J, Jernigan T, Archibald S, Harris MJ, Jeste DV. Quantitative magnetic resonance imaging of the brain in late-life schizophrenia. Am J Psychiatry. 1995;152:447-449.
FREE FULL TEXT
26. Zipursky RB, Marsh L, Lim KO, DeMent S, Shear PK, Sullivan EV, Murphy GM, Csernansky JG, Pfefferbaum A. Volumetric MRI assessment of temporal lobe structures in schizophrenia. Biol Psychiatry. 1994;35:501-516.
FULL TEXT
|
ISI
| PUBMED
27. Bornstein RA, Schwarzkopf SB, Olson SC, Nasrallah HA. Third-ventricle enlargement and neuropsychological deficit in schizophrenia. Biol Psychiatry. 1992;31:954-961.
FULL TEXT
|
ISI
| PUBMED
28. Bogerts B, Ashtari M, Degreef G, Alvir JMJ, Bilder RM, Lieberman JA. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res. 1990;35:1-13.
ISI
| PUBMED
29. Suddath RL, Christison GW, Torrey BF, Casanova MF, Weinberger DR. Anatomical abnormalities in the brain of monozygotic twins discordant for schizophrenia. N Engl J Med. 1990;322:789-794.
ABSTRACT
30. Raz S, Raz N. Structural abnormalities in the major psychoses: a quantitative review of the evidence from computerized imaging. Psychol Bull. 1990;108:93-106.
FULL TEXT
|
ISI
| PUBMED
31. Rossi A, Stratta P, Mancini F, Ga |
